WhatsApp, WeChat & Telegram : +8801886229488, Email : aiopharma@outlook.com
Bangladesh Makes Strides in Biopharmaceutical Production with Bevixa, a Biosimilar to Avastin
In a significant step toward self-reliance in healthcare, Bangladesh has successfully developed and launched Bevixa, a biosimilar of Avastin, a widely used cancer treatment drug. This achievement marks a milestone in the country’s growing biopharmaceutical industry and holds immense promise…